LUM and breast cancer: In fact, a new multi-omics analysis has identified a positive relationship between the expression of lumican (LUM) and stromal scores, CAF infiltration, and poor responses to chemotherapy in BC, thus underscoring lumican expression as a stromal-derived regulator of TME and treatment resistance [228].